Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2005-6-20
pubmed:abstractText
Natural killer-T (NKT) cells are rich in the liver. However, their involvement in liver injury is not fully understood. We developed here a new murine model of NKT-cell-activation-associated liver injury, and investigated a role of tumor necrosis factor alpha (TNF-alpha) and Fas in pathogenesis. We injected intraperitoneally alpha-galactosylceramide (alpha-GalCer), an NKT-cell stimulant, into D-galactosamine (GalN)-sensitized mice. Survival rate, pathological changes of the liver, and plasma concentrations of cytokines were studied. Alpha-GalCer/GalN administration gave a lethal effect within 7 h, making pathological changes such as massive parenchymal hemorrhage, hepatocyte apoptosis, sinusoidal endothelial cell injury, and close apposition of lymphocytes to apoptotic hepatocytes. Anti-NK1.1 mAb-pretreated mice and Valpha14NKT knock out (KO) mice did not develop liver injury. Tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) were elevated at 4 h in the plasma. These cytokines were produced by hepatic lymphocytes as demonstrated by in vitro stimulation with alpha-GalCer. The lethal effect was suppressed in TNF-alpha KO mice, TNF receptor-1 KO mice, and lpr/lpr (Fas deficient) mice, whereas it was not in IFN-gamma KO mice. These results indicate that the present liver injury is characterized by parenchymal hemorrhage and hepatocyte apoptosis, and mediated by TNF-alpha secretion and direct cytotoxicity of alpha-GalCer-activated NKT cells.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0945-6317
pubmed:author
pubmed:issnType
Print
pubmed:volume
446
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
663-73
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:15906084-Animals, pubmed-meshheading:15906084-Apoptosis, pubmed-meshheading:15906084-Disease Models, Animal, pubmed-meshheading:15906084-Drug-Induced Liver Injury, pubmed-meshheading:15906084-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:15906084-Female, pubmed-meshheading:15906084-Flow Cytometry, pubmed-meshheading:15906084-Galactosamine, pubmed-meshheading:15906084-Galactosylceramides, pubmed-meshheading:15906084-In Situ Nick-End Labeling, pubmed-meshheading:15906084-Interferon-gamma, pubmed-meshheading:15906084-Killer Cells, Natural, pubmed-meshheading:15906084-Liver, pubmed-meshheading:15906084-Liver Diseases, pubmed-meshheading:15906084-Mice, pubmed-meshheading:15906084-Mice, Knockout, pubmed-meshheading:15906084-Receptors, Tumor Necrosis Factor, pubmed-meshheading:15906084-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:15906084-Tumor Necrosis Factor-alpha
pubmed:year
2005
pubmed:articleTitle
A murine model of NKT cell-mediated liver injury induced by alpha-galactosylceramide/d-galactosamine.
pubmed:affiliation
Department of Hepatology, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan. rolahidek@med.osaka-cu.ac.jp
pubmed:publicationType
Journal Article